Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Young, KH

Published Date

  • November 2020

Published In

Volume / Issue

  • 34 / 11

Start / End Page

  • 3075 - 3076

PubMed ID

  • 32398791

Pubmed Central ID

  • 32398791

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/s41375-020-0861-6

Language

  • eng

Conference Location

  • England